Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 Strains Are Dependent on Serine Proteases for Entry Throughout the Human Respiratory Tract
Overview
Authors
Affiliations
Background: The SARS-CoV-2 Omicron BA.1 variant emerged in late 2021 and became the globally dominant variant by January 2022. Authentic virus and pseudovirus systems have shown Omicron spike has an increased dependence on the endosomal pathway for entry.
Methods: We investigated the entry mechanisms of Omicron, Delta, and ancestral viruses in cell models that represent different parts of the human respiratory tract, including nasal epithelial cells (hNECs), large-airway epithelial cells (LAECs), small-airway epithelial cells, and embryonic stem cell-derived type II alveolar cells.
Findings: Omicron had an early replication advantage in LAECs, while Delta grew to higher titers in all cells. Omicron maintained dependence on serine proteases for entry in all culture systems. While serine protease inhibition with camostat was less robust for Omicron in hNECs, endosomal entry was not enhanced.
Conclusions: Our findings demonstrate that entry of Omicron BA.1 SARS-CoV-2 is dependent on serine proteases for entry throughout the respiratory tract.
Funding: This work was supported by The Medical Research Future Fund (MRF9200007; K.S., J.M.P.) and the DHHS Victorian State Government grant (Victorian State Government; DJPR/COVID-19; K.S, J.M.P.). K.S. is supported by a National Health and Medical Research Council of Australia Investigator grant (APP1177174).
Qing E, Salgado J, Wilcox A, Gallagher T PLoS Pathog. 2024; 20(12):e1012757.
PMID: 39621785 PMC: 11637440. DOI: 10.1371/journal.ppat.1012757.
Dynamin independent endocytosis is an alternative cell entry mechanism for multiple animal viruses.
Ojha R, Jiang A, Mantyla E, Quirin T, Modhira N, Witte R PLoS Pathog. 2024; 20(11):e1012690.
PMID: 39541404 PMC: 11594517. DOI: 10.1371/journal.ppat.1012690.
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
Ren W, Hong W, Yang J, Zou J, Chen L, Zhou Y J Clin Invest. 2024; 134(18).
PMID: 39286971 PMC: 11405045. DOI: 10.1172/JCI174304.
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins.
Focosi D, Spezia P, Maggi F Vaccines (Basel). 2024; 12(8).
PMID: 39204013 PMC: 11358953. DOI: 10.3390/vaccines12080887.
Houghton M, Balland E, Gartner M, Thomas B, Subbarao K, Williamson G Biofactors. 2024; 50(6):1268-1286.
PMID: 38886986 PMC: 11627474. DOI: 10.1002/biof.2084.